US3800039A
(en)
|
1970-10-21 |
1974-03-26 |
Mead Johnson & Co |
Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines
|
US4607034A
(en)
*
|
1979-10-29 |
1986-08-19 |
Mitsubishi Yuka Pharmaceutical Co., Ltd. |
Quinazoline derivatives and pharmaceutical composition thereof
|
JPS5677265A
(en)
*
|
1979-11-28 |
1981-06-25 |
Mitsubishi Yuka Yakuhin Kk |
Novel quinazoline derivative
|
JPS58172379A
(ja)
*
|
1982-04-02 |
1983-10-11 |
Showa Denko Kk |
新規なキナゾリン誘導体
|
JPS60120872A
(ja)
*
|
1983-12-01 |
1985-06-28 |
Kyowa Hakko Kogyo Co Ltd |
新規なヘテロ環状化合物及び強心剤
|
US4797419A
(en)
|
1986-11-03 |
1989-01-10 |
Warner-Lambert Company |
Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
|
US5120843A
(en)
|
1987-04-27 |
1992-06-09 |
Upjohn |
Pharmaceutically active amines
|
CA1338012C
(en)
|
1987-04-27 |
1996-01-30 |
John Michael Mccall |
Pharmaceutically active amines
|
IT1222867B
(it)
|
1987-10-12 |
1990-09-12 |
Zambon Spa |
Ftalazino derivati ad attivita' farmaceutica
|
JPH02167277A
(ja)
|
1988-09-19 |
1990-06-27 |
Kyowa Hakko Kogyo Co Ltd |
新規なジアジン化合物
|
JPH0413669A
(ja)
|
1990-04-27 |
1992-01-17 |
Mitsui Toatsu Chem Inc |
新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
US5308850A
(en)
|
1991-09-30 |
1994-05-03 |
Merck Frosst Canada, Inc. |
(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
US5290798A
(en)
|
1991-09-30 |
1994-03-01 |
Merck Frosst Canada, Inc. |
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
TW225528B
(de)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
GB9321557D0
(en)
|
1992-11-03 |
1993-12-08 |
Zeneca Ltd |
Carboxamide derivatives
|
CA2150550A1
(en)
|
1992-12-01 |
1994-06-09 |
Melissa S. Egbertson |
Fibrinogen receptor antagonists
|
JP3229693B2
(ja)
*
|
1993-02-22 |
2001-11-19 |
協和醗酵工業株式会社 |
ピペラジン誘導体
|
ATE189217T1
(de)
|
1993-03-19 |
2000-02-15 |
Merck & Co Inc |
Phenoxyphenylessigsäurederivate
|
ATE202345T1
(de)
|
1993-03-29 |
2001-07-15 |
Astrazeneca Ab |
Heterozyklische derivate als plätchenaggregationsinhibitoren
|
JPH09503666A
(ja)
|
1993-10-15 |
1997-04-15 |
メルク・パテント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツンク |
アッセイ方法
|
US5446062A
(en)
|
1993-11-12 |
1995-08-29 |
Abbott Laboratories |
((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
US5496857A
(en)
|
1994-03-17 |
1996-03-05 |
Targosz; Eugene F. |
Whitefly insecticide
|
US5538991A
(en)
|
1994-09-14 |
1996-07-23 |
Merck & Co., Inc. |
Endothelin antagonists bearing 5-membered heterocyclic amides
|
GB9510757D0
(en)
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
WO1996009818A1
(en)
|
1994-09-27 |
1996-04-04 |
Merck & Co., Inc. |
Endothelin receptor antagonists for the treatment of emesis
|
CA2133231A1
(en)
|
1994-09-29 |
1996-03-30 |
Kuen-Yuan Hwang |
Process for preparing carbonate compounds
|
TW321649B
(de)
|
1994-11-12 |
1997-12-01 |
Zeneca Ltd |
|
WO1996017833A1
(en)
|
1994-12-09 |
1996-06-13 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
CA2216796C
(en)
|
1995-03-30 |
2003-09-02 |
Pfizer Inc. |
Quinazoline derivatives
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US5972955A
(en)
|
1995-06-06 |
1999-10-26 |
Dr. Reddy's Research Foundation |
Water soluble C-ring analogues of 20(S)-camptothecin
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
CN1196731A
(zh)
|
1995-06-29 |
1998-10-21 |
诺瓦蒂斯有限公司 |
二糖基化1,2-二醇作为唾液酰-路易斯x和唾液酰-路易斯a的模拟物
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
GB9516709D0
(en)
|
1995-08-15 |
1995-10-18 |
Zeneca Ltd |
Medicament
|
WO1997012613A1
(en)
|
1995-10-05 |
1997-04-10 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
HUT76265A
(en)
|
1995-10-19 |
1997-07-28 |
Gyogyszerkutato Intezet |
Pyrimidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
FR2744449B1
(fr)
|
1996-02-02 |
1998-04-24 |
Pf Medicament |
Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
AR005600A1
(es)
|
1996-02-02 |
1999-06-23 |
Syngenta Ltd |
Composiciones herbicidas quimicamente estables de quelatos metalicos de dionas herbicidas, y proceso para su produccion
|
FR2744450A1
(fr)
|
1996-02-02 |
1997-08-08 |
Pf Medicament |
Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
EP0880508B1
(de)
|
1996-02-13 |
2003-04-16 |
AstraZeneca AB |
Chinazolinderivate und deren verwendung als vegf hemmer
|
ATE211134T1
(de)
|
1996-03-05 |
2002-01-15 |
|
4-anilinochinazolin derivate
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
KR19980018486A
(ko)
|
1996-08-09 |
1998-06-05 |
다께다 구니오 |
디메틸프로판디올 화합물
|
EP0954315A2
(de)
|
1996-09-13 |
1999-11-10 |
Sugen, Inc. |
Verwendung von quinazolinderivate zur herstellung eines arzneimittels zur behandlung hyperproliferativer hautkrankheiten
|
US6004967A
(en)
|
1996-09-13 |
1999-12-21 |
Sugen, Inc. |
Psoriasis treatment with quinazoline compounds
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
EP0882717B1
(de)
|
1996-10-01 |
2010-09-08 |
Kyowa Hakko Kirin Co., Ltd. |
Stickstoff enthaltende heterocyclische verbindungen
|
ATE238286T1
(de)
|
1997-01-17 |
2003-05-15 |
Naeja Pharmaceutical Inc |
Neue triazole als therapeutische mittel gegen pilzinfektionen
|
AU5999798A
(en)
|
1997-02-13 |
1998-09-08 |
Zeneca Limited |
Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
|
DE69838172T2
(de)
|
1997-08-22 |
2008-04-10 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
JPH1180131A
(ja)
*
|
1997-09-01 |
1999-03-26 |
Mitsubishi Chem Corp |
エチニルピリミジン誘導体
|
DE19743435A1
(de)
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
JP2001519345A
(ja)
|
1997-10-02 |
2001-10-23 |
メルク エンド カムパニー インコーポレーテッド |
プレニルタンパク質トランスフェラーゼの阻害剤
|
ATE496035T1
(de)
|
1998-03-31 |
2011-02-15 |
Kyowa Hakko Kirin Co Ltd |
Stickstoffenthaltende heterocyclische verbindungen
|
AU4072799A
(en)
|
1998-05-12 |
1999-12-13 |
American Home Products Corporation |
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
|
CN1311773A
(zh)
|
1998-06-08 |
2001-09-05 |
先灵公司 |
神经肽y5受体拮抗剂
|
EP0982300A3
(de)
|
1998-07-29 |
2000-03-08 |
Societe Civile Bioprojet |
Alkylamine ohne Imidazolring als Histamin-H3-antagonisten und deren therapeutische Anwendung
|
CN1158266C
(zh)
|
1998-10-01 |
2004-07-21 |
阿斯特拉曾尼卡有限公司 |
化合物
|
KR100860295B1
(ko)
|
1998-10-08 |
2008-09-25 |
아스트라제네카 아베 |
퀴나졸린 유도체
|
ES2226485T3
(es)
|
1998-12-23 |
2005-03-16 |
Eli Lilly And Company |
Amidas aromaticas.
|
US6146560A
(en)
|
1999-01-22 |
2000-11-14 |
Behi; Mohammad |
Process for forming an article from recycled ceramic molding compound
|
ATE482946T1
(de)
|
1999-02-10 |
2010-10-15 |
Astrazeneca Ab |
Chinazolinderivate als angiogenesehemmer und zwischenprodukte dafür
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
KR20020029419A
(ko)
|
1999-07-07 |
2002-04-18 |
다비드 에 질레스 |
퀴나졸린 유도체
|
PL354923A1
(en)
|
1999-09-21 |
2004-03-22 |
Astrazeneca Ab |
Quinazoline compounds and pharmaceutical compositions containing them
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
GB9922173D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
WO2001021596A1
(en)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Quinazoline derivatives and their use as pharmaceuticals
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
AU2001235804A1
(en)
|
2000-03-06 |
2001-09-17 |
Astrazeneca Ab |
Therapy
|
ES2267748T3
(es)
|
2000-04-07 |
2007-03-16 |
Astrazeneca Ab |
Compuestos de quinazolina.
|
UA73993C2
(uk)
|
2000-06-06 |
2005-10-17 |
Астразенека Аб |
Хіназолінові похідні для лікування пухлин та фармацевтична композиція
|
ATE413394T1
(de)
|
2000-06-24 |
2008-11-15 |
Astrazeneca Ab |
Guanidin-derivate von chinazoin zur behandlung von autoimmunkrankheiten
|
WO2002002534A1
(en)
|
2000-07-03 |
2002-01-10 |
Astrazeneca Ab |
Quinazolines with therapeutic use
|
AU2001293207A1
(en)
*
|
2000-08-18 |
2002-03-04 |
Cor Therapeutics, Inc. |
Nitrogenous heterocyclic compounds
|
EA005809B1
(ru)
*
|
2000-08-18 |
2005-06-30 |
Милленниум Фармасьютикалз, Инк. |
Производные хиназолина в качестве ингибиторов киназы
|
ES2361582T3
(es)
|
2000-08-18 |
2011-06-20 |
Millennium Pharmaceuticals, Inc. |
Compuestos [(quinazolin-4-il)piperazin-4-il]tiocarboxamida como inhibidores de la fosforilación de un receptor de pdgf.
|
EP1309569B1
(de)
*
|
2000-08-18 |
2010-10-06 |
Millennium Pharmaceuticals, Inc. |
N-aryl-{4-[7-(alkoxy)Chinazolin-4-yl]Piperazinyl}Carboxamid-Verbindungen als PDGF-Rezeptoren Hemmer
|
BR0113358A
(pt)
|
2000-08-21 |
2003-07-01 |
Astrazeneca Ab |
Derivado de quinazolina ou de um seu sal farmaceuticamente aceitável, processo para a sua preparação, composição farmacêutica, e, uso do derivado ou de um seu sal farmaceuticamente aceitável
|
DE10042059A1
(de)
|
2000-08-26 |
2002-03-07 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
US6939866B2
(en)
|
2000-10-13 |
2005-09-06 |
Astrazeneca Ab |
Quinazoline derivatives
|
JP2004511479A
(ja)
|
2000-10-13 |
2004-04-15 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体
|
WO2002034744A1
(en)
|
2000-10-25 |
2002-05-02 |
Astrazeneca Ab |
Quinazoline derivatives
|
ATE502928T1
(de)
|
2000-11-01 |
2011-04-15 |
Millennium Pharm Inc |
Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
|
AU2002226687B9
(en)
|
2001-01-26 |
2005-10-20 |
Btg International Limited |
Benzylamine analogue
|
TWI245761B
(en)
|
2001-03-01 |
2005-12-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
AU2002254152A1
(en)
|
2001-03-08 |
2002-09-24 |
Millennium Pharmaceuticals |
(homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases
|
WO2002085895A1
(en)
|
2001-04-19 |
2002-10-31 |
Astrazeneca Ab |
Quinazoline derivatives
|
GB0110797D0
(en)
|
2001-05-02 |
2001-06-27 |
Celltech R&D Ltd |
Chemical compounds
|
WO2002092578A1
(en)
|
2001-05-14 |
2002-11-21 |
Astrazeneca Ab |
Quinazoline derivatives
|
WO2002092579A1
(en)
|
2001-05-14 |
2002-11-21 |
Astrazeneca Ab |
4-anilinoquinazoline derivatives
|
WO2002092577A1
(en)
|
2001-05-14 |
2002-11-21 |
Astrazeneca Ab |
Quinazoline derivatives
|
AU2002350105A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel quinazolines and uses thereof
|
ES2307799T3
(es)
|
2001-06-28 |
2008-12-01 |
Pfizer Products Inc. |
Benzotiofenos, benzofuranos e indoles sustituidos con triamida como inhibidores de la proteina de transferencia de trigliceridos microsomal (mtp) y/o la secrecion de la apoliproteina b (apo b).
|
GB0128109D0
(en)
|
2001-11-23 |
2002-01-16 |
Astrazeneca Ab |
Therapeutic use
|
GB0128122D0
(en)
|
2001-11-23 |
2002-01-16 |
Astrazeneca Ab |
Therapeutic use
|
WO2003054819A2
(en)
|
2001-12-12 |
2003-07-03 |
Paradata Systems Inc. |
Global integrated payment system
|
WO2003051849A1
(fr)
|
2001-12-19 |
2003-06-26 |
Ube Industries, Ltd. |
Procede de production de quinazoline-4-one et derive de celle-ci
|
PL211694B1
(pl)
|
2001-12-24 |
2012-06-29 |
Astrazeneca Ab |
Podstawiona pochodna chinazoliny, jej zastosowania oraz jej kompozycja farmaceutyczna
|
DE60328461D1
(de)
|
2002-01-28 |
2009-09-03 |
Ube Industries |
Verfahren zur herstellung eines chinazolin-4-onderivats
|
WO2003066602A1
(fr)
|
2002-02-06 |
2003-08-14 |
Ube Industries, Ltd. |
Procede relatif a l'elaboration d'un compose 4-aminoquinazoline
|
US7148249B2
(en)
|
2002-09-12 |
2006-12-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
|
GB0223532D0
(en)
|
2002-10-09 |
2002-11-13 |
British Biotech Pharm |
Antibacterial agents
|
AR041198A1
(es)
|
2002-10-11 |
2005-05-04 |
Otsuka Pharma Co Ltd |
Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
|
SE0203828D0
(sv)
|
2002-12-20 |
2002-12-20 |
Astrazeneca Ab |
Chemical compounds
|
TW200510311A
(en)
|
2002-12-23 |
2005-03-16 |
Millennium Pharm Inc |
CCr8 inhibitors
|
EP1590327A1
(de)
|
2002-12-23 |
2005-11-02 |
Millennium Pharmaceuticals, Inc. |
Ccr8 inhibitoren
|
US7138412B2
(en)
*
|
2003-03-11 |
2006-11-21 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives useful as serine protease inhibitors
|
EP1660473A2
(de)
|
2003-03-24 |
2006-05-31 |
Luitpold Pharmaceuticals, Inc. |
Xanthone, thioxanthone und acridinone als dna-pk-hemmer
|
TW200500362A
(en)
|
2003-04-09 |
2005-01-01 |
Japan Tobacco Inc |
5-membered heteroaromatic ring compound and pharmaceutical use thereof
|
CA2525124A1
(en)
|
2003-05-13 |
2004-11-25 |
Schering Corporation |
Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
|
MXPA06001081A
(es)
|
2003-07-31 |
2006-04-24 |
Irm Llc |
Compuestos biciclicos y composiciones como inhibidores de pdf.
|
US7456189B2
(en)
|
2003-09-30 |
2008-11-25 |
Boehringer Ingelheim International Gmbh |
Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
|
WO2005042497A2
(en)
|
2003-10-28 |
2005-05-12 |
Vertex Pharmaceuticals, Incorporated |
Benzimidazoles useful as modulators of ion channels
|
JP5208911B2
(ja)
|
2009-12-09 |
2013-06-12 |
株式会社東芝 |
空調制御装置および空調制御方法
|